Tom Mikkelsen , MD, FRCP

Henry Ford Cancer Institute

Dr. Mikkelsen received his MD from the University of Calgary, Canada and completed clinical training in neurology at the Montreal Neurologic Institute. Following this, he did post-doctoral training in tumor and molecular biology at the Ludwig Institute for Cancer Research in Montreal and then in La Jolla, California. Since 1992, he has led the brain tumor program at Henry Ford Hospital, responsible for building the clinical trials program and laboratory of tumor biology. Together with Dr. Kalkanis and other scientists, he helped assemble what has become the Hermelin Brain Tumor Center, a basic and clinical research resource for patients in Michigan and surrounding states. Dr. Mikkelsen is currently the Medical Director of the Precision Medicine and Clinical Trials Program for Henry Ford Health System